| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 773 | 751 | +3.0% |
| EBITDA | 64.7 | 124 | −47.9% |
| EBITDA margin | 8.4% | 16.5% | −8.2 pts |
| Profit before tax | 65.0 | 128 | −49.0% |
| Net profit | 47.6 | 96.8 | −50.8% |
| EPS | ₹1.30 | ₹2.64 | −50.8% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 6,411 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 559 | 559 | 534 | 276 | 106 | ||
| 5,852 | — | — | — | — | ||
| 2,966 | 2,944 | 2,844 | 2,754 | 2,482 | ||
| — | +3.5% | +3.3% | +11.0% | — | ||
| 390 | 450 | 500 | 480 | 316 | ||
| 13.2% | 15.3% | 17.6% | 17.4% | 12.7% | ||
| 328 | 389 | 444 | 430 | 266 | ||
| 284 | 333 | 371 | 370 | 240 | ||
| 9.6% | 11.3% | 13.1% | 13.4% | 9.7% | ||
| ₹7.74 | ₹9.07 | ₹10.11 | ₹10.07 | ₹6.52 | ||
| — | −10.2% | +0.3% | +54.4% | — | ||
| — | 473 | 312 | 458 | 329 | ||
| — | −66.9 | −58.1 | −37.1 | −35.3 | ||
| 406 | 406 | 253 | 421 | 294 | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 6,410.6 | |
| - Cash, Equiv & ST Investments | 105.5 | 275.9 | 533.7 | 558.9 | 558.9 | |
| Enterprise Value | — | — | — | — | 5,851.7 | |
| Revenue | 2,482.0 | 2,754.0 | 2,843.9 | 2,944.3 | 2,966.5 | |
| Growth %, YoY | — | +11.0 | +3.3 | +3.5 | — | |
| EBITDA | 315.6 | 479.9 | 499.8 | 449.9 | 390.4 | |
| Margin % | 12.71 | 17.43 | 17.58 | 15.28 | 13.16 | |
| EBIT | 265.5 | 430.0 | 443.7 | 388.6 | 327.7 | |
| Net Income | 239.5 | 369.9 | 371.2 | 333.2 | 284.0 | |
| Margin % | 9.65 | 13.43 | 13.05 | 11.32 | 9.57 | |
| EPS, Adj (current shares) | 6.52 | 10.07 | 10.11 | 9.07 | 7.74 | |
| Growth %, YoY | — | +54.4 | +0.3 | -10.2 | — | |
| Cash from Operations | 328.8 | 458.0 | 311.5 | 473.1 | — | |
| Capital Expenditures | -35.3 | -37.1 | -58.1 | -66.9 | — | |
| Free Cash Flow | 293.5 | 420.9 | 253.4 | 406.2 | 406.2 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Jyothy Labs (NSE: JYOTHYLAB) had a market capitalisation of ₹6,428 crore at the 29 October 2026 close (₹175.06 a share), a PE ratio of 22.6 on the last four quarters' profit and a price-to-book ratio of 4.05. In FY26 its standalone net profit was ₹333 crore on revenue of ₹2,944 crore; in Q1 FY27 (April–June 2026) it was ₹47.6 crore, down 50.8% year on year. It had no borrowings on 31 March 2026. Promoters held 62.89% of the shares on 30 September 2026.
Jyothy Labs' PE ratio is 22.6 at the 29 October 2026 close (₹175.06 a share): a market capitalisation of ₹6,428 crore divided by standalone net profit of ₹284 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹333 crore) it is 19.3.
Jyothy Labs' net worth — shareholders' equity in its standalone balance sheet — was ₹1,589 crore on 31 March 2026, up 14.9% from ₹1,383 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹6,428 crore at the 29 October 2026 close.
Jyothy Labs' book value per share was ₹43.26 on 31 March 2026: shareholders' equity of ₹1,589 crore divided by the 36.72 crore shares in issue, up 14.9% from ₹37.65 a year earlier. The share price at the 29 October 2026 close was ₹175.06.
Jyothy Labs' price-to-book (PB) ratio is 4.05 at the 29 October 2026 close: a market capitalisation of ₹6,428 crore divided by shareholders' equity (book value) of ₹1,589 crore on 31 March 2026. That is a book value of ₹43.26 per share against a share price of ₹175.06.
In FY26, Jyothy Labs' return on equity (ROE) was 22.4% and its return on capital employed (ROCE) was 24.2%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 29.4% and ROCE 32.1%.
Jyothy Labs' dividend yield is 2.00% at the 29 October 2026 close: dividends of ₹3.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹175.06. They were ₹3.50 on 29 June 2026.
Jyothy Labs' market capitalisation was ₹6,428 crore at the 29 October 2026 close: 36.72 crore shares at ₹175.06 each.
Yes. Jyothy Labs had no borrowings on 31 March 2026 (standalone balance sheet), and it held ₹816 crore of cash, bank balances and current investments.
Jyothy Labs' debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹1,589 crore. A year earlier, on 31 March 2025, it was 0.00.
Jyothy Labs' basic earnings per share (EPS) were ₹9.07 in FY26, against ₹10.11 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹7.74.
In 2026, Jyothy Labs has declared one dividend: ₹3.50 with record date 29 June 2026.
Jyothy Labs will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.
Promoters held 62.89% of Jyothy Labs on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Jyothy Labs generated ₹473 crore of cash from operations and spent ₹66.9 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹406 crore. In FY25 it was ₹253 crore.
Jyothy Labs' latest results are for Q1 FY27 (April–June 2026), filed on 12 August 2026: standalone net profit ₹47.6 crore, down 50.8% from ₹96.8 crore in Q1 FY26; revenue from operations ₹773 crore, up 3.0% year on year.
On 30 September 2026, Jyothy Labs' shares were held by promoters 62.89%, foreign portfolio investors (FII/FPI) 14.48%, domestic institutions (DII) 9.86% (including mutual funds at 8.00%) and retail and other non-institutional investors 12.77%. Over the year, FII holding was up 2.36 percentage points from 12.12% and DII holding was down 6.22 percentage points from 16.08%.
In FY26 (April 2025–March 2026), Jyothy Labs' standalone net profit was ₹333 crore, down 10.2% from ₹371 crore in FY25, on revenue from operations of ₹2,944 crore (up 3.5%). Over three years, from FY23, net profit was up 39.1%.
At the 29 October 2026 closing prices, on FY26 net profit, Jyothy Labs' PE ratio is 19.3, the lowest of the four: HUL 28.3, Godrej Consumer 56.5 and Dabur India 44.0, a peer average of 42.9. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On FY26 standalone figures, against HUL, Godrej Consumer and Dabur India: Jyothy Labs' operating margin of 13.2% is the lowest of the four (HUL 21.4%, Godrej Consumer 21.9%, Dabur India 16.2%; peer average 19.8%); its return on equity of 22.4% is the second highest of the four (HUL 31.4%, Godrej Consumer 18.7%, Dabur India 20.0%; peer average 23.3%); its revenue growth over three years of 5.9% a year is the second highest of the four (HUL 1.6% a year, Godrej Consumer 7.3% a year, Dabur India 2.6% a year; peer average 3.8% a year).
In FY26, Jyothy Labs earned net profit of ₹333 crore on revenue of ₹2,944 crore, against ₹15,427 crore on ₹61,975 crore for HUL. Jyothy Labs' operating margin was 13.2% (HUL 21.4%) and its return on equity 22.4% (HUL 31.4%). At the 29 October 2026 close, Jyothy Labs' market capitalisation was ₹6,428 crore against ₹4,36,677 crore for HUL, and its PE ratio on FY26 profit 19.3 against 28.3.
From Jyothy Labs' own standalone results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Standalone figures from the company's filings with NSE; prices are NSE closing prices.